Javier Escaned

ORCID: 0000-0003-4932-0112
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cerebrovascular and Carotid Artery Diseases
  • Peripheral Artery Disease Management
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Issues in Pregnancy
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Disease and Adiposity
  • Cardiac Health and Mental Health
  • Coronary Artery Anomalies
  • Venous Thromboembolism Diagnosis and Management
  • Advanced MRI Techniques and Applications
  • Aortic aneurysm repair treatments
  • Cardiovascular Health and Disease Prevention
  • Lipoproteins and Cardiovascular Health
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cardiac electrophysiology and arrhythmias

Hospital Clínico San Carlos
2016-2025

Universidad Complutense de Madrid
2016-2025

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2015-2025

Centro de Investigación Biomédica en Red
2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2024-2025

Instituto de Salud Carlos III
2013-2025

Comunidad de Madrid
2023-2025

Duran i Reynals Hospital
2024

Institut d'Investigació Biomédica de Bellvitge
2024

Ospedale Santa Corona
2024

Juhani Knuuti William Wijns Antti Saraste Davide Capodanno Emanuele Barbato and 95 more Christian Funck‐Brentano Eva Prescott Robert F. Storey Christi Deaton Thomas Cuisset Stefan Agewall Kenneth Dickstein Thor Edvardsen Javier Escaned Bernard J. Gersh Pavel Svítil Martine Gilard David Hasdai Róbert Hatala Felix Mahfoud Josep Masip Claudio Muneretto Marco Valgimigli Stephan Achenbach Jeroen J. Bax Franz-Josef Neumann Udo Sechtem Adrian Banning Nikolaos Bonaros Héctor Bueno Raffaele Bugiardini Alaide Chieffo Filippo Crea Martin Czerny Victoria Delgado Paul Dendale Frank A. Flachskampf H. Gohlke Erik Lerkevang Grove Stefan James Demosthenes G. Katritsis Ulf Landmesser Maddalena Lettino Christian M. Matter Hendrik M. Nathoe Alexander Niessner Carlo Patrono Anna Sonia Petronio S. Pettersen Raffaele Piccolo Massimo Piepoli Bogdan A Popescu Lorenz Räber Dimitrios Richter Marco Roffi Franz Xaver Roithinger Е. V. Shlyakhto Dirk Sibbing Sigmund Silber Iain Simpson Miguel Sousa‐Uva Panos Vardas Adam Witkowski Jose Luis Zamorano Stephan Achenbach Stefan Agewall Emanuele Barbato Jeroen J. Bax Davide Capodanno Thomas Cuisset Christi Deaton Kenneth Dickstein Thor Edvardsen Javier Escaned Christian Funck‐Brentano Bernard J. Gersh Martine Gilard David Hasdai Róbert Hatala Felix Mahfoud Josep Masip Claudio Muneretto Eva Prescott Antti Saraste Robert F. Storey Pavel Svítil Marco Valgimigli Stephan Windecker Victor Aboyans Colin Baigent Jean-Philippe Collet Veronica Dean Victoria Delgado Donna Fitzsimons Chris P Gale Diederick E. Grobbee Sigrun Halvorsen Gerhard Hindricks Bernard Iung Peter Jüni

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This can be modified lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve stabilization regression. The have long, stable periods but also become unstable at any time, typically due an acute atherothrombotic event caused rupture erosion. However, chronic, most often...

10.1093/eurheartj/ehz425 article EN European Heart Journal 2019-08-31

with the European Association for Study of Diabetes (EASD).

10.1093/eurheartj/eht108 article EN European Heart Journal 2013-08-30

Background —PTCA of a coronary stenosis without documented ischemia at noninvasive stress testing is often performed, but its benefit unproven. Coronary pressure–derived fractional flow reserve (FFR) an invasive index severity that reliable substitute for testing. A value 0.75 identifies stenoses with hemodynamic significance. Methods and Results —In 325 patients whom PTCA was planned who did not have ischemia, FFR the measured. If >0.75, were randomly assigned to deferral (deferral...

10.1161/01.cir.103.24.2928 article EN Circulation 2001-06-19

The purpose of this study was to develop an adenosine-independent, pressure-derived index coronary stenosis severity.Assessment severity with fractional flow reserve (FFR) requires that resistance is stable and minimized. This usually achieved by administration pharmacological agents such as adenosine. In 2-part study, we determine whether there a time when naturally minimized at rest assess the diagnostic efficiency, compared FFR, new adenosine-free over time.A total 157 stenoses were...

10.1016/j.jacc.2011.11.003 article EN cc-by-nc-nd Journal of the American College of Cardiology 2011-12-10

This Consensus Document is the first of two reports summarizing views an expert panel organized by European Association Percutaneous Cardiovascular Interventions (EAPCI) on clinical use intracoronary imaging including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The document appraises role to guide percutaneous coronary interventions (PCIs) in practice. Current evidence regarding impact guidance cardiovascular outcomes summarized, patients or lesions most likely...

10.1093/eurheartj/ehy285 article EN European Heart Journal 2018-05-16

This consensus document, a summary of the views an expert panel organized by European Association Percutaneous Cardiovascular Interventions (EAPCI), appraises importance ischaemia with non-obstructive coronary arteries (INOCA). Angina pectoris affects approximately 112 million people globally. Up to 70% patients undergoing invasive angiography do not have obstructive artery disease, more common in women than men, and large proportion INOCA as cause their symptoms. present wide spectrum...

10.1093/eurheartj/ehaa503 article EN European Heart Journal 2020-06-01
Daniel J.F.M. Thuijs A. Pieter Kappetein Patrick W. Serruys Friedrich‐Wilhelm Mohr Marie‐Claude Morice and 95 more Michael J. Mack David R. Holmes Nick Curzen Piroze Davierwala Thilo Noack Milan Milojevic Keith D. Dawkins Bruno R. da Costa Peter Jüni Stuart J. Head Filip Casselman Bernard De Bruyne Evald Høj Christiansen Juan M. Ruiz-Nodar Paul Vermeersch Werner Schultz Manel Sabaté Giulio Guagliumi Herko Grubitzsch Karl Stangl Olivier Darremont Mohamed Bentala Peter den Heijer István Préda Robert Stoler Michael J. Mack Tamás Szerafin John K. Buckner Myles S. Guber Niels Verberkmoes Ferdi Akca Ted Feldman Friedhelm Beyersdorf Benny Drieghe Keith G. Oldroyd Geoff Berg Anders Jeppsson Kimberly Barber Kevin Wolschleger John Heiser Pim van der Harst Massimo A. Mariani Hermann Reichenspurner Christoffer Stark Mika Laine Paul C. Ho John C. Chen Richard Zelman Phillip A. Horwitz Andrzej Bochenek Agata Krauze Christina Grothusen Dariusz Dudek George P. Heyrich Piroze Davierwala Thilo Noack Philippe Kolh Victor Legrand Pedro Coelho Stephan Ensminger Boris Nasseri Richard Ingemansson Göran Olivecrona Javier Escaned Reddy Guera Sérgio Berti Marie‐Claude Morice Alaide Chieffo M. Nicholas Burke Michael Mooney Alvise Spolaor Christian Hagl Michael Näbauer Maarten J. Suttorp Ronald A. Stine Thomas McGarry Scott Lucas Knut Endresen Andrew Taussig Kevin Accola Umberto Canosi Iván Horváth Louis Cannon John D. Talbott C W Akins Robert S. Kramer Michael Aschermann William A. Killinger Inga Narbute David R. Holmes Francesco Burzotta Ad J.J.C. Bogers Felix Zijlstra Hélène Eltchaninoff Jacques Berland

10.1016/s0140-6736(19)31997-x article EN The Lancet 2019-09-02

To assess platelet function profiles in diabetic and nondiabetic patients on aspirin clopidogrel therapy, two patient populations were included to investigate the 1) acute effects of a 300-mg loading dose (group 1, n = 52) 2) long-term 2, 120) compared with already treatment. Patients stratified according presence type 2 diabetes. Platelet aggregation was assessed using light transmittance aggregometry (groups 1 2). activation (P-selectin expression PAC-1 binding) determined whole-blood flow...

10.2337/diabetes.54.8.2430 article EN Diabetes 2005-08-01

The clinical value of percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) is not established by randomized trials. This study should compare the benefit PCI vs. optimal medical therapy (OMT) on health status in patients with at least one CTO.Three hundred and ninety-six were enrolled a prospective randomized, multicentre, open-label, controlled trial to treatment OMT 2:1 randomization ratio. primary endpoint was change assessed Seattle angina questionnaire (SAQ)...

10.1093/eurheartj/ehy220 article EN European Heart Journal 2018-04-04

Stenting an angiographically intermediate but functionally non-significant stenosis is controversial. Nevertheless, it has been questioned if deferral of a lesion on the basis fractional flow reserve (FFR) measurement, safe, especially long term. Five-year follow-up DEFER trial showed that outcome after percutaneous coronary intervention (PCI) based FFR ≥ 0.75 excellent and was not improved by stenting. The aim this study to investigate validity position very In 325 patients scheduled for...

10.1093/eurheartj/ehv452 article EN European Heart Journal 2015-09-23

Outcomes after percutaneous coronary interventions in diabetic patients are shadowed by the increased rate of recurrence compared with nondiabetic patients.We conducted a multicenter, randomized trial to demonstrate efficacy sirolimus-eluting stents standard prevent restenosis de novo lesions native arteries. The primary end point was in-segment late lumen loss as assessed quantitative angiography at 9-month follow-up. stratified diabetes treatment status. One hundred sixty were (80...

10.1161/circulationaha.105.562421 article EN Circulation 2005-10-03

Background Quantitative flow ratio ( QFR ) is a novel modality for physiological lesion assessment based on 3‐dimensional vessel reconstructions and contrast velocity estimates. We evaluated the value of online during routine invasive coronary angiography procedural feasibility, diagnostic performance, agreement with pressure‐wire–derived fractional reserve FFR as gold standard in an international multicenter study. Methods Results FAVOR II E‐J (Functional Assessment by Various Flow...

10.1161/jaha.118.009603 article EN cc-by-nc-nd Journal of the American Heart Association 2018-07-06

In comparison with non-occlusive lesions, percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) represents a greater challenge for the interventionalist, due to lower procedural success rates, relatively higher incidence complications and increased rate restenosis. The European Registry Chronic Total Occlusion (ERCTO) was created goal evaluating real impact CTO PCI in context, trying analyse rates success, technical information from procedures patient outcome.Data...

10.4244/eijv7i4a77 article EN EuroIntervention 2011-08-01
Coming Soon ...